BSTC BioSpecifics Technologies Corp.

--- - BioSpecifics Technologies Corp. (NASDAQ:BSTC) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 74,100 shares, an increase of 22.5% from the October 31st total of 60,500 shares. Approximately 1.3% of the companys stock ...

--- - New York State Common Retirement Fund cut its stake in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 12.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,600 shares of the ...

--- - 'Endo International said Wednesday it has completed its previously announced $540 million acquisition of BioSpecifics Technologies Corp., a Wilmington biopharmaceutical company. Under the terms of the agreement, Endo (NASDAQ: ENDP), which is based in Dublin, Ireland, and has its U.S. headquarters in Malvern, paid $88.50 per share to BioSpecifics shareholders in the all-cash transaction.'

--- - Wells Fargo Company MN grew its stake in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 14.8% in the third quarter, HoldingsChannel.com reports. The firm owned 138,508 shares of the biopharmaceutical companys stock after buying an additional 17,835 shares during the quarter...

--- - Royce Associates LP cut its stake in BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 1.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 132,058 shares of the biopharmaceutical companys stock after selling ...

--- - BNP Paribas Arbitrage SA grew its position in shares of BioSpecifics Technologies Corp. (NASDAQ:BSTC) by 388.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,464 shares of the biopharmaceutical companys ...